Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2022-11-04FDA Approved: ALLERGY RELIEF — Supplemental Application (Publix Super Markets Inc)
FDA approved a supplemental application for Allergy Relief (fexofenadine hydrochloride) from Publix Super Markets Inc under ANDA 212971.
-
FDA approval · 2022-11-02FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic promethazine hydrochloride under an original ANDA. The approval authorizes marketing of the gen…
-
FDA approval · 2022-11-01FDA Approved: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex's azelastine hydrochloride and fluticasone propionate nasal spray, updating/expanding the…
-
CLINICAL_TRIALS withdrawal · 2022-10-31Clinical Trial Update: Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis [Phase 3]
A Phase 3 randomized trial comparing Cloratadd D (loratadine + pseudoephedrine sulfate) to Claritin D was withdrawn.
-
FDA label_change · 2022-10-28FDA Approved: CHILDRENS XYZAL ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application to modify the labeling of CHILDRENS XYZAL ALLERGY (levocetirizine dihydrochloride) for pediatric use…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial assessing Anti-Bet v 1 monoclonal antibodies for reducing symptoms of seasonal allergic rhinitis; study completed with results…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: The Effect of Cetirizine on Bronchoconstriction [Phase 4]
Phase 4 trial examining the effect of cetirizine on bronchoconstriction in patients with allergic rhinitis and asthma completed.
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR [Phase 2, Phase 3]
Clinical trial update on SLIT with dust mite allergen for allergic rhinitis, spanning Phase 2 and Phase 3, with unknown status and mechanism…
-
FDA approval · 2022-09-30FDA Approved: RYALTRIS — Supplemental Application (HIKMA SPECIALTY USA INC.)
The FDA approved a supplemental application for RYALTRIS, a combination nasal spray of olopatadine hydrochloride and mometasone furoate, sub…
-
FDA approval · 2022-09-29FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (NorthStar RxLLC)
FDA approved phenylephrine hydrochloride under an original application for temporary relief of nasal congestion due to the common cold, hay …
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass [Phase 1, Phase 2]
Follow-up study 5-6 years after ILIT with Birch and Grass allergens for allergic rhinitis; completed Phase 1/2 trial.
-
FDA approval · 2022-09-19FDA Tentative Approval: RUGBY MOMETASONE FUROATE NASAL — Supplemental Application (Rugby Laboratories)
The FDA issued tentative approval for Rugby Mometasone Furoate Nasal from Rugby Laboratories under a supplemental application, indicating th…
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis [Phase 2]
Phase 2 clinical trial update on Tacrosolv for allergic conjunctivitis and allergic rhinitis has completed.
-
FDA approval · 2022-08-22FDA Approved: GUAIFENESIN AND PSEUDOEPHEDRINE HCL — Original Application (Granules India Ltd)
FDA approved Granules India Ltd's guaifenesin and pseudoephedrine HCl as an Original Application (ANDA) for a generic combination product.
-
CLINICAL_TRIALS withdrawal · 2022-08-05Clinical Trial Update: Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis [Phase 3]
Phase 3 trial of Magnólia nasal gel for allergic rhinitis was withdrawn.
-
FDA approval · 2022-07-15FDA Approved: RUGBY MOMETASONE FUROATE NASAL — Supplemental Application (Rugby Laboratories)
FDA granted a supplemental approval for Rugby Mometasone Furoate Nasal (mometasone furoate) from Rugby Laboratories.
-
FDA approval · 2022-07-08FDA Approved: ALLERGY RELIEF — Supplemental Application (Publix Super Markets Inc)
FDA approved a supplemental application for Allergy Relief containing fexofenadine hydrochloride, submitted by Publix Super Markets Inc.
-
FDA approval · 2022-06-16FDA Approved: FLUNISOLIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved the original application for flunisolide from Ingenus Pharmaceuticals, confirming the generic product's approval for its indica…
-
EMA approval · 2022-06-09EMA Authorised: Desloratadine Teva (desloratadine) — Teva B.V
The EMA authorised Desloratadine Teva (desloratadine) for allergic rhinitis (perennial and seasonal) with Teva B.V. as the marketing authori…
-
FDA approval · 2022-05-31FDA Approved: FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (Walgreens Company)
FDA approved Walgreens' generic combination tablet of fexofenadine hydrochloride and pseudoephedrine hydrochloride under an original ANDA fo…
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Efficacy of Artemisia Pollen Specific Allergen Immunotherapy [Phase 4]
Phase 4 trial update evaluating the efficacy of Artemisia pollen-specific allergen immunotherapy for allergic rhinitis.
-
FDA approval · 2022-05-17FDA Approved: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Dr. Reddy's Laboratories' generic combination product of fexofenadine HCl and pseudoephedrine HC…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Effect of Bacterial Lysate on Nasal Carriage of Staphylococcus Aureus [Phase 3]
Phase 3 clinical trial evaluating the effect of a bacterial lysate on nasal carriage of Staphylococcus aureus in patients with allergic rhin…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: The Effect of Early Radiofrequency Turbinate Reduction on Persistent Allergic Rhinitis [Phase 3]
Phase 3 clinical trial investigating early radiofrequency turbinate reduction for persistent allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis [Phase 3]
Phase 3 clinical trial evaluating how long azelastine hydrochloride nasal spray takes to relieve symptoms in allergic rhinitis has been comp…